Stereotactic radiotherapy for non-small cell lung cancer: From concept to clinical reality. 2011 update;Radiothérapie stéréotaxique des cancers broncho-pulmonaires non à petites cellules: d'un concept à une réalité clinique. Actualités en 2011

Cancer/Radiotherapie

Volumn 15, Issue 6-7, 2011, Pages 522-526

  Girard, N ^a,b   Mornex, F ^b,c  

^a LOUIS PRADEL HOSPITAL   (France)

^b UNIVERSITÉ LYON 1   (France)

^c CENTRE HOSPITALIER LYON SUD   (France)

Author keywords

Lung cancer; Radiotherapy; Respiratory gating; Stereotactic body radiation therapy; Surgery

Indexed keywords

CANCER CONTROL; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER STAGING; CLINICAL EFFECTIVENESS; COMORBIDITY; FOLLOW UP; HUMAN; LUNG NON SMALL CELL CANCER; PRIORITY JOURNAL; PROGNOSIS; RADIATION BEAM; RADIATION DOSE FRACTIONATION; RADICAL RESECTION; SHORT SURVEY; SMOKING; STEREOTACTIC TREATMENT; SURVIVAL TIME; TREATMENT OUTCOME;

CARCINOMA, NON-SMALL-CELL LUNG; DOSE FRACTIONATION; HUMANS; LUNG NEOPLASMS; MULTICENTER STUDIES AS TOPIC; POSITRON-EMISSION TOMOGRAPHY; RADIATION INJURIES; RADIOSURGERY; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SURGERY, COMPUTER-ASSISTED; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 80053313582     PISSN: 12783218     EISSN: 17696658     Source Type: Journal    
DOI: 10.1016/j.canrad.2011.07.241     Document Type: Short Survey

References (26)

1. The national lung screening trial research team Reduced lung-cancer mortality with low-dose computed tomographic screening. New Engl J Med 2011, 365:395-409.
2. Armstrong J.G., Minsky B.D. Radiation therapy for medically inoperable stage I and II non-small cell lung cancer. Cancer Treat Rev 1989, 16:247-255.
3. Girard N., Mornex F. Chimio-radiothérapie exclusive des cancers bronchiques non à petites cellules localement évolués. Cancer Radiother 2007, 11:67-76.
4. Dosoretz D.E., Katin M.J., Blitzer P.H., Rubenstein J.H., Galmarini D.H., Garton G.R., et al. Medically inoperable lung carcinoma: the role of radiation therapy. Semin Radiat Oncol 1996, 6:98-104.
5. Cesaretti J.A., Pennathur A., Rosenstein B.S., Swanson S.J., Fernando H.C. Stereotactic radiosurgery for thoracic malignancies. Ann Thorac Surg 2008, 85:S785-S791.
6. Lagerwaard F.J., Haasbeek C.J.A., Smit E.F., Slotman B.J., Senan S. Outcomes of risk adapted fractionated stereotactic radiotherapy for stage I non-small cell lung cancer. Int J Radiat Oncol Biol Phys 2008, 70:685-692.
7. Timmerman R., Paulus R., Galvin J., Michalski J., Straube W., Bradley J., et al. Stereotactic body radiation therapy for inoperable early-stage lung cancer. JAMA 2010, 303:1070-1076.
8. Onishi H., Shirato H., Nagata Y., Hiraoka M., Fujino M., Gomi K., et al. Hypofractionated stereotactic radiotherapy (HypoFXSRT) for stage I non-small cell lung cancer: updated results of 257 patients in a Japanese multi-institutional study. J Thorac Oncol 2007, 2:S94-S100.
9. Onishi H., Nagata S., Hiraoka M., Kokubo Y., Karasawa K., Shioyama Y. When is SBRT best?. J Thoracic Oncol 2011, 6:S262.
10. Lagerwaard F.J., Verstegen N.E., Haasbeek C.J., Slotman B., Paul M.A., Smit E.F., et al. Stereotactic ablative radiotherapy (SABR) in potentially operable stage I non-small cell lung cancer patients. J Thoracic Oncol 2011, 6:S278.
11. Falcoz P.E., Conti M., Brouchet L., Chocron S., Puyraveau M., Mercier M., et al. The thoracic surgery scoring system (thoracoscore): risk model for in-hospital death in 15,183 patients requiring thoracic surgery. J Thorac Cardiovasc Surg 2007, 133:325-332.
12. Verstegen N.E., Lagerwaard F.J., Haasbeek C.J., Slotman B., Senan S. Stereotactic ablative radiotherapy (SABR) in patients with stage I non-small cell lung cancer: a comparison of patients with and without pathological proof. J Thoracic Oncol 2011, 6:S281.
13. Palma D., Lagerwaard F.J., Rodrigues G., Haasbeek C.J., Senan S. Curative treatment of stage I non-small cell Lung cancer in patients with severe COPD: stereotactic radiotherapy outcomes and systematic review. J Thoracic Oncol 2011, 6:S384.
14. Phernambucq E.C., Lagerwaard F.J., Van de Ven P.M., Groepenhoff H., Postmus P.E., Slotman B., et al. Quantifying pulmonary function changes after stereotactic ablative radiotherapy (SABR) for stage I non-small-cell lung cancer. J Thoracic Oncol 2011, 6:S385.
15. Dahele M., Palma D., Lagerwaard F.J., Slotman B., Senan S. Late radiological changes after stereotactic ablative radiotherapy of primary lung tumors. J Thoracic Oncol 2011, 6:543.
16. Clarke K., Taremi M., Freeman M., Fung S., Dahele M., Bezjak A. FDG-PET SUV uptake as a predictor of outcome in stereotactic body radiotherapy (SBRT) for non-small cell lung cancer (NSCLC). J Thoracic Oncol 2011, 6:S544.
17. De Ruysscher D., Faivre-Finn C., Nestle U., Hurkmans C.W., Le Péchoux C., Price A., et al. European organisation for research and treatment of cancer recommendations for planning and delivery of high-dose, high-precision radiotherapy for lung cancer. J Clin Oncol 2010, 28:5301-5310.
18. Rosenzweig K. Normal tissue constraints for SBRT. J Thoracic Oncol 2011, 6:S85.
19. Bongers E.M., Haasbeek C.J., Lagerwaard F.J., Slotman B., Senan S. Chest wall toxicity following risk-adapted stereotactic radiotherapy for early-stage lung cancer. J Thoracic Oncol 2011, 6:S277.
20. Nicastri D.G., Wisnivesky J.P., Litle V.R., Yun J., Chin C., Dembitzer F.R., et al. Thoracoscopic lobectomy: report on safety, discharge independence, pain, and chemotherapy tolerance. J Thorac Cardiovasc Surg 2008, 135:642-647.
21. Timmerman R., Mcgarry R., Yiannoutsos C., Papiez L., Tudor K., Deluca J., et al. Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer. J Clin Oncol 2006, 24:4833-4839.
22. Haasbeek C.J., Lagerwaard F.J., Slotman B., Senan S. Late outcomes of stereotactic ablative radiotherapy (SABR) for centrally located stage I lung cancer. J Thoracic Oncol 2011, 6:S542.
23. Guckenberger M. Advances in on-board image guidance. J Thoracic Oncol 2011, 6:S147.
24. Mornex F., Udrescu C., De Bari B., Michel-Amadry G., Chapet O. The EXACTRAC snap verification (SV), a new tool for ensuring the quality control for stereotactic body radiation therapy (SBRT). The French experience. J Thoracic Oncol 2010, 5:S110.
25. Peulen H., Damen E., Scheenstra A., Sonke J.J., Tinteren H.V., Baas P., et al. Design of a hybrid study: combined stereotactic body radiotherapy and conventional fractionation in stage II and III non small cell lung cancer with peripheral tumors. J Thoracic Oncol 2011, 6:S811.
26. Senan S., Lagerwaard F. Stereotactic radiotherapy for stage I lung cancer: current results and new developments. Cancer Radiother 2010, 14:115-118.